Riboflavin has a positive effect on clinical symptoms in individuals with dihydrolipoamide dehydrogenase (E3) deficiency [26], FAD synthase and transporter deficiencies [25] plus respiratory chain complex I disorders, specifically ACAD9 deficiency [27, 36]. The gene discussed is ACAD9; the disease is hyperinsulinemic hypoglycemia, familial, 4.